NASDAQ : ATHE

Alterity Therapeutics Limited

$4.98 USD

-$0.1 (-2.06%)

Volume
9.37K
Average Volume
52.48K
Market Capitalization
$45.14M
P/E Ratio
-7.20
Dividend Yield
0.00%
Price Target
Year High
$7.00
Year Low
$2.66
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$21.98
Insider Activity Summary (Last 12 Months)
Insiders Buying

0

Insiders Selling

0

Amount of Insider Selling

-$

ATHE Insider Buying/Selling by Quarter
ATHE Insider Trading History
Insider Name Title Date Transaction Cost Filing Date
Babarczy Julian Michael director 2026-06-15 A-Award 1 2026-06-23
Gozlan Lawrence Bernard director 2026-06-15 A-Award 1 2026-06-23
Cunningham Ann Michelle director: 2026-04-17 0 2026-04-29
Stamler David Allen director, officer: Chief Executive Officer 2026-04-15 0 2026-04-15
Stamler David Allen director, officer: Chief Executive Officer 2026-04-15 0 2026-04-15
Stamler David Allen director, officer: Chief Executive Officer 2026-04-15 0.028 2026-04-15
Stamler David Allen director, officer: Chief Executive Officer 2026-04-15 0.01 2026-04-15
Stamler David Allen director, officer: Chief Executive Officer 2026-04-15 0.003 2026-04-15
Stamler David Allen director, officer: Chief Executive Officer 2026-04-15 0.0086 2026-04-15
Gozlan Lawrence Bernard director 2026-04-10 0 2026-04-10
Gozlan Lawrence Bernard director 2026-04-10 0.028 2026-04-10
Gozlan Lawrence Bernard director 2026-04-10 0.01 2026-04-10
Babarczy Julian Michael director: 2026-04-10 0 2026-04-10
Marks Peter Ashley director 2026-04-10 0 2026-04-10
Marks Peter Ashley director 2026-04-10 0.028 2026-04-10
Marks Peter Ashley director 2026-04-10 0.01 2026-04-10
Macnish Niven Abby Sarah officer: Chief Financial Officer 2026-04-09 0 2026-04-09
Macnish Niven Abby Sarah officer: Chief Financial Officer 2026-04-10 0.028 2026-04-09